经皮胆道介入中的患者辐射剂量:基于多中心研究的诊断参考水平推荐
该多中心研究向200家高级诊疗医院发放问卷,调查不同经皮胆道介入的剂量面积乘积(DAP)和透视时间(FT),以75百分位设定国家诊断参考水平。23家机构回复(12%),纳入565例次介入;初始经皮胆道介入DAP中位数2162 cGy·cm2显著高于随访介入的464 cGy·cm2,超声引导与透视引导穿刺的初始介入DAP无显著差异。推荐初始介入DRL为4300 cGy·cm2,随访介入为1400 cGy·cm2。
要点
- 推荐经皮胆道介入国家DRL:初始介入4300 cGy·cm2,随访介入1400 cGy·cm2。
- 初始介入DAP中位数2162 cGy·cm2,显著高于随访介入的464 cGy·cm2(p < 0.0001)。
- 超声引导与透视引导胆管穿刺的初始介入DAP无显著差异(2162 vs 2132 cGy·cm2,p = 0.85)。
核心结论
- 经皮胆道介入的DAP和FT因中心和介入类型不同而差异很大;与透视引导相比,超声引导胆管穿刺并未降低DAP;推荐初始介入DRL为4300 cGy·cm2、随访介入DRL为1400 cGy·cm2。
研究设计与样本
- 多中心研究,向200家高级诊疗医院发放问卷,调查超声或透视引导胆管穿刺的不同经皮胆道介入的DAP和FT;23家机构回复(12%),包括9个介入放射科和14个消化科;共纳入565例次经皮胆道介入,涵盖19种不同介入;推荐国家DRL设定为所有DAP的第75百分位。
诊断标准与关键数值
- 推荐国家DRL:初始经皮胆道介入(建立经肝通道)为4300 cGy·cm2,随访经皮胆道介入(经肝通道已建立)为1400 cGy·cm2;初始介入DAP中位数2162 cGy·cm2,随访介入DAP中位数464 cGy·cm2;初始介入超声引导穿刺DAP 2162 cGy·cm2 vs 透视引导穿刺2132 cGy·cm2(p = 0.85);DAP范围4-21,510 cGy·cm2,FT范围0.07-180.33 min。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 问卷回复率为12%(23/200家机构)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Percutaneous biliary interventions (PBIs) can be associated with a high patient radiation dose, which can be reduced when national diagnostic reference levels (DRLs) are kept in mind. The aim of this multicentre study was to investigate patient radiation exposure in different percutaneous biliary interventions, in order to recommend national DRLs.
METHODS: A questionnaire asking for the dose area product (DAP) and the fluoroscopy time (FT) in different PBIs with ultrasound- or fluoroscopy-guided bile duct punctures was sent to 200 advanced care hospitals. Recommended national DRLs are set at the 75th percentile of all DAPs.
RESULTS: Twenty-three facilities (9 interventional radiology depts. and 14 gastroenterology depts.) returned the questionnaire (12%). Five hundred sixty-five PBIs with 19 different interventions were included in the analysis. DAPs (range 4-21,510 cGy·cm2) and FTs (range 0.07-180.33 min) varied substantially depending on the centre and type of PBI. The DAPs of initial PBIs were significantly (p < 0.0001) higher (median 2162 cGy·cm2) than those of follow-up PBIs (median 464 cGy·cm2). There was no significant difference between initial PBIs with ultrasound-guided bile duct puncture (2162 cGy·cm2) and initial PBIs with fluoroscopy-guided bile duct puncture (2132 cGy·cm2) (p = 0.85). FT varied substantially (0.07-180.33 min).
CONCLUSIONS: DAPs and FTs in percutaneous biliary interventions showed substantial variations depending on the centre and the type of PBI. PBI with US-guided bile duct puncture did not reduce DAP, when compared to PBI with fluoroscopy-guided bile duct puncture. National DRLs of 4300 cGy·cm2 for initial PBIs and 1400 cGy·cm2 for follow-up PBIs are recommended.
KEY POINTS: • DAPs and FTs in percutaneous biliary interventions showed substantial variations depending on the centre and the type of PBI. • PBI with US-guided bile duct puncture did not reduce DAP when compared to PBI with fluoroscopy-guided bile duct puncture. • DRLs of 4300 cGy·cm2for initial PBIs (establishing a transhepatic tract) and 1400 cGy·cm2for follow-up PBIs (transhepatic tract already established) are recommended.
引用
- Schmitz D, Vogl T, Nour-Eldin NA, et al. Patient radiation dose in percutaneous biliary interventions: recommendations for DRLs on the basis of a multicentre study. Eur Radiol. 2019. PMID: 31016441. doi:10.1007/s00330-019-06208-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。